fingolimod zentiva 0,5 mg cietās kapsulas
zentiva, k.s., czech republic - fingolimods - kapsula, cietā - 0,5 mg
fingolimod medochemie 0,5 mg cietās kapsulas
medochemie ltd., cyprus - fingolimods - kapsula, cietā - 0,5 mg
fingolimod teva 0,5 mg cietās kapsulas
teva gmbh, germany - fingolimods - kapsula, cietā - 0,5 mg
efigalo 0,5 mg cietās kapsulas
krka, d.d., novo mesto, slovenia - fingolimods - kapsula, cietā - 0,5 mg
inzolfi 0,5 mg cietās kapsulas
sandoz pharmaceuticals d.d., slovenia - fingolimods - kapsula, cietā - 0,5 mg
lumykras
amgen europe bv - sotorasib - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
fingolimod stada 0,5 mg cietās kapsulas
stada arzneimittel ag, germany - fingolimods - kapsula, cietā - 0,5 mg
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
inzolfi 0,25 mg cietās kapsulas
sandoz d.d., slovenia - fingolimods - kapsula, cietā - 0,25 mg
bonaxon 0,5 mg cietās kapsulas
egis pharmaceuticals plc, hungary - fingolimods - kapsula, cietā - 0,5 mg